NCT05944666 is a NA clinical trial of Multimodal technology (MT) in Stroke Rehabilitation, sponsored by Moscow Scientific and Practical Center of Medical Rehabilitation, Restorative and Sports Medicine.

What drugs are being tested in NCT05944666?

Interventions in NCT05944666: Multimodal technology (MT), Conventional rehabilitation.

What condition does NCT05944666 study?

NCT05944666 studies Stroke Rehabilitation.

Is NCT05944666 still recruiting?

NCT05944666 is currently status unknown. Last updated 13 July 2023.

Last reviewed 2023-07-13 · How we verify

NCT05944666

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Substantiation and Standardization of the Multimodal Cognitive-motor Rehabilitation System for Afterstroke Patients

Status unknown NA Last updated 13 July 2023

What this trial tests

NA trial testing Multimodal technology (MT) in Stroke Rehabilitation in 405 participants. Status unknown.

Timeline

15 May 2023

Primary endpoint
31 December 2024

31 December 2025

Quick facts

Lead sponsor	Moscow Scientific and Practical Center of Medical Rehabilitation, Restorative and Sports Medicine
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	405
Start date	15 May 2023
Primary completion	31 December 2024
Estimated completion	31 December 2025
Sites	1 location across Russia

Drugs / interventions tested

Multimodal technology (MT)
Conventional rehabilitation

Conditions studied

Stroke Rehabilitation — all drugs for Stroke Rehabilitation →

Sponsor

Moscow Scientific and Practical Center of Medical Rehabilitation, Restorative and Sports Medicine

Who can join

Adults 45 to 75, any sex, with Stroke Rehabilitation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to develop and scientifically substantiate a standardized system of multimodal cognitive-motor rehabilitation and its differentiated application in patients with cerebral stroke, according to verified rehabilitation potential based on the patient's rehabilitation model for the stages of medical rehabilitation, including inpatient-replacement technologies

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Multimodal technology (MT)

Trials testing the same drug.

NCT05391919 — Multimodal Correction of Post-stroke Motor and Cognitive Impairments · NA · completed

Other recruiting trials for Stroke Rehabilitation

Currently open trials in the same condition.

NCT07228754 — How Realistic Are Caregivers' Expectations in Patients With Subacute Stroke? · recruiting
NCT06998485 — Substrates for Post-Stroke Arm Rehabilitation · NA · recruiting
NCT07229053 — Hospitalisation Duration in Stroke Patients · recruiting
NCT06965894 — Lower Extremity Pressure Splints in HP · NA · recruiting
NCT06898073 — Dual-task Training During Curved Walking in Stroke Patients · NA · recruiting

Other Moscow Scientific and Practical Center of Medical Rehabilitation, Restorative and Sports Medicine trials

Trials by the same sponsor.

NCT05423626 — Innovative Technologies in Restoring Gait and Balance Funtions in Ischemic Stroke Patients at the Inpatient Stage · NA · unknown
NCT05391919 — Multimodal Correction of Post-stroke Motor and Cognitive Impairments · NA · completed
NCT05053672 — ReOxy Therapy in the Rehabilitation of Chronic Low Back Pain Patients With Comorbidity · NA · completed
NCT05214521 — Digital Interactive Technologies in Rehabilitation of Post-sroke Patients With Impaired Fine Function of the Hand · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05944666 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Moscow Scientific and Practical Center of Medical Rehabilitation, Restorative and Sports Medicine
Last refreshed: 13 July 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05944666.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing